Pulmonary Rehabilitation and Smoking

Smoking Clinical Trial

Official title: Effectiveness of Pulmonary Rehabilitation in Smoker Patients With COPD

Status Completed

Clinical Trial Summary

Pulmonary rehabilitation (PR) is known to reduce dyspnea, increase exercise capacity, reduce psychological symptoms and improve quality of life in COPD patients. Some patients continue to smoke despite their illness. Smoking does not create a contraindication to PR. There is insufficient evidence on the effectiveness of PR programs in smoking COPD patients. The purpose of this study, PR completed the program to determine the effectiveness of PR smoker COPD patients.

Clinical Trial Description

Pulmonary rehabilitation (PR) is known to reduce dyspnea, increase exercise capacity, reduce psychological symptoms and improve quality of life in COPD patients. Some patients continue to smoke despite their illness. Smoking does not create a contraindication to PR. There is insufficient evidence on the effectiveness of PR programs in smoking COPD patients. The purpose of this study, PR completed the program to determine the effectiveness of PR smoker COPD patients. People who have completed the PR program, smoking and not smoking will be included into the study.

Data of carbon monoxide diffusion test, body plethysmography, 6-min walk test, blood gas analysis, mMRC dyspnea scale, hospital anxiety depression scale, SGRQ and SF-36 quality of life questionnaire performed before and after the program will be analyzed. ;

Related Conditions & MeSH terms

• Rehabilitation; Tobacco Use
• Smoking

• NCT number: NCT03671187
• Study type: Interventional
• Source: Izmir Katip Celebi University
• Status: Completed
• Phase: N/A
• Start date: January 2015
• Completion date: August 2018